后循环大血管闭塞卒中桥接取栓与直接取栓的比较:双国登记与荟萃分析
本研究基于台湾与韩国两项全国性登记数据,纳入873例后循环大血管闭塞取栓患者,采用倾向评分匹配比较桥接取栓(BT)与直接取栓(DT),并更新荟萃分析。结果显示BT与更好的90天功能结局和更低死亡率相关,且不增加症状性颅内出血风险;证据等级为Class III。
要点
- 后循环大血管闭塞取栓患者中,桥接取栓与90天功能结局改善相关。
- 桥接取栓与更低死亡率相关,且不增加症状性颅内出血风险。
- 结论尚需随机对照试验进一步验证。
核心结论
- 后循环大血管闭塞卒中患者中,桥接取栓与更好的90天功能结局和更低死亡率相关,且不增加出血风险。
研究设计与样本
- 观察性研究,基于台湾与韩国协作登记数据,纳入873例接受取栓的后循环大血管闭塞患者,其中桥接取栓281例、直接取栓592例。
- 采用倾向评分匹配调整基线差异,匹配队列各205例。
- 系统综述与荟萃分析纳入39项观察性研究、7288例患者,比较桥接取栓与直接取栓。
主要发现
- 桥接取栓组90天mRS评分中位数3 vs 4,每改善1分的调整OR 1.44(95%CI 1.09-1.91)。
- 桥接取栓组死亡率17.4% vs 26.9%,调整OR 0.51(95%CI 0.33-0.81)。
- 成功再灌注比例79.3% vs 81.1%,症状性颅内出血比例2.5% vs 2.9%,两组相当。
- 倾向评分匹配队列中,桥接取栓仍与更好功能结局(OR 1.44,95%CI 1.00-2.07)和更低死亡率(匹配OR 0.45,95%CI 0.26-0.78)相关。
- 荟萃分析显示桥接取栓与更高90天mRS 0-2(OR 1.57,95%CI 1.28-1.94)、mRS 0-3(OR 1.33,95%CI 1.05-1.68)比例及更低死亡率(OR 0.77,95%CI 0.61-0.97)相关,不增加症状性颅内出血风险(OR 1.01,95%CI 0.71-1.44)。
临床怎么用
- 对于符合条件接受取栓的后循环大血管闭塞卒中患者,可考虑桥接取栓以改善功能结局并降低死亡率。
- 桥接取栓未增加症状性颅内出血风险,但需结合患者个体情况评估。
局限性
- 研究为观察性设计,存在残余混杂可能。
- 结论需等待随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The role of IV thrombolysis before endovascular thrombectomy (bridging thrombectomy, BT) in posterior circulation large-vessel occlusion stroke remains uncertain. This study evaluated the effectiveness and safety of BT compared with direct thrombectomy (DT) using data from 2 nationwide registries and an updated meta-analysis. METHODS: Patients from collaborative registries in Taiwan and South Korea who underwent thrombectomy for vertebral, basilar, and posterior cerebral artery occlusions were included. This observational study included hospital-based registry data with standardized collection of treatments and outcomes. Propensity score matching was applied to adjust for baseline differences between BT and DT groups. Outcomes included 90-day modified Rankin Scale (mRS) score, mortality, successful reperfusion, and symptomatic intracranial hemorrhage (sICH). We also performed a systematic review and meta-analysis of observational studies comparing BT vs DT in posterior circulation large-vessel occlusion stroke. RESULTS: Among the combined 9,942 patients, 873 (median age 71, 32% female) who underwent thrombectomy for posterior circulation stroke were analyzed. Of them, 281 received BT and 592 received DT. BT was associated with a lower 90-day mRS score (median 3 vs 4; adjusted odds ratio [OR] 1.44 per 1-point improvement, 95% CI 1.09-1.91) and lower mortality (17.4% vs 26.9%; adjusted OR 0.51, 95% CI 0.33-0.81). The proportions of successful reperfusion (79.3% vs 81.1%) and sICH (2.5% vs 2.9%) were comparable. In propensity score-matched cohorts (n = 205 each), BT remained associated with better functional outcomes (OR 1.44, 95% CI 1.00-2.07) and reduced mortality (matched OR 0.45, 95% CI 0.26-0.78). The meta-analysis, which included 39 studies and 7,288 patients, confirmed that BT was associated with higher odds of achieving 90-day mRS score 0-2 (OR 1.57, 95% CI 1.28-1.94), 90-day mRS score 0-3 (OR 1.33, 95% CI 1.05-1.68), and lower mortality (OR 0.77, 95% CI 0.61-0.97), without an increased risk of sICH (OR 1.01, 95% CI 0.71-1.44). DISCUSSION: BT was associated with better 90-day functional outcomes and lower mortality, without increasing hemorrhagic risk in posterior circulation large-vessel occlusion stroke. These findings support the use of BT in eligible patients, pending further validation from randomized trials. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that in patients with posterior circulation stroke undergoing thrombectomy, previous IV thrombolysis is associated with better 90-day functional outcomes and lower mortality without increasing hemorrhagic risk.
引用
- Chen CH, Kim YS, Lee CW, et al. Bridging or Direct Thrombectomy in Posterior Circulation Large-Vessel Occlusion Stroke: Analysis of Binational Registries and Meta-Analysis. Neurology. 2025. PMID: 41252660. doi:10.1212/WNL.0000000000214353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。